Old Web
English
Sign In
Acemap
>
Paper
>
P76.79 Osimertinib in Poor PS Patients with T790M-Positive Advanced NSCLC after Progression of EGFR TKI Treatments (NEJ032B)
P76.79 Osimertinib in Poor PS Patients with T790M-Positive Advanced NSCLC after Progression of EGFR TKI Treatments (NEJ032B)
2021
R.Saito
Yukari Tsubata
A Nakamura
Hiroshige Yoshioka
M. Morita
R. Honda
N. Kanaji
M. Watanabe
D. Jingu
Taku Nakagawa
K. Nakazawa
A. Mouri
S. Takeuchi
Naoki Furuya
Y. Akazawa
K. Miura
E. Ichihara
Kunihiko Kobayashi
Shuko Morita
Takeshi Isobe
Keywords:
Medicine
Internal medicine
Oncology
T790M
Osimertinib
egfr tki
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]